Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RLMD

Relmada Therapeutics Inc

May 15 • 10:46AM ET

7.15

-0.27 -3.69 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NMRA AXSM SUPN ACAD PRTA

| Held by: VTI VXF PSIL ITOT ONEQ PRFZ IBRN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	12.25%	Shs Outstand	104.89M	Perf Week	-2.37%
Market Cap	749.60M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.31%	Shs Float	92.04M	Perf Month	2.09%
Enterprise Value	515.64M	PEG	-	EPS next Q	-0.19	Inst Own	50.29%	Short Float	5.81%	Perf Quarter	92.11%
Income	-58.88M	P/S	-	EPS this Y	44.83%	Inst Trans	43.78%	Short Ratio	2.90	Perf Half Y	82.77%
Sales	0.00M	P/B	3.43	EPS next Y	-19.75%	ROA	-44.77%	Short Interest	5.35M	Perf YTD	47.96%
Book/sh	2.09	P/C	3.20	EPS next 5Y	12.24%	ROE	-48.83%	52W High	8.00 -10.67%	Perf Year	1628.71%
Cash/sh	2.23	P/FCF	-	EPS past 3/5Y	35.03% 17.54%	ROIC	-26.92%	52W Low	0.38 1772.28%	Perf 3Y	131.28%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.57% 6.14%	Perf 5Y	-78.88%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	55.59%	Oper. Margin	-	ATR (14)	0.44	Perf 10Y	-33.83%
Dividend Ex-Date	-	Quick Ratio	18.26	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.83	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	18.26	EPS Q/Q	61.90%	SMA20	-2.81%	Beta	0.41	Target Price	12.80
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	3.38%	Rel Volume	0.54	Prev Close	7.42
Employees	17	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	82.26%	Avg Volume	1.84M	Price	7.15
IPO	Jun 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.84% -	Trades		Volume	232,542	Change	-3.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)